XML 23 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
Intangible Assets
6 Months Ended
Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Disclosure [Text Block]
Note 5 – Intangible Assets
 
Intangible assets at March 31, 2018 and September 30, 2017 consist of the following:
 
 
 
Useful
 
Gross
 
Accumulated
 
 
 
March 31, 2018
 
Life (years)
 
Amount
 
Amortization
 
Net
 
Acquired Customer Base
 
5 to 15
 
$
768,000
 
$
607,000
 
$
161,000
 
Know How
 
15
 
 
512,000
 
 
333,000
 
 
179,000
 
Trade Names
 
Indefinite
 
 
293,000
 
 
-
 
 
293,000
 
Patents
 
20
 
 
378,000
 
 
14,000
 
 
364,000
 
Biomedical Technologies
 
5
 
 
260,000
 
 
260,000
 
 
-
 
 
 
 
 
$
2,211,000
 
$
1,214,000
 
$
997,000
 
 
 
 
Useful
 
Gross
 
Accumulated
 
 
 
September 30, 2017
 
Life (years)
 
Amount
 
Amortization
 
Net
 
Acquired Customer Base
 
5 to 15
 
$
737,000
 
$
551,000
 
$
186,000
 
Know How
 
15
 
 
512,000
 
 
316,000
 
 
196,000
 
Trade Names
 
Indefinite
 
 
281,000
 
 
-
 
 
281,000
 
Patents
 
20
 
 
333,000
 
 
9,000
 
 
324,000
 
Biomedical Technologies
 
5
 
 
260,000
 
 
260,000
 
 
-
 
 
 
 
 
$
2,123,000
 
$
1,136,000
 
$
987,000
 
 
Amortization expense for the three months ended March 31, 2018 and 2017 was $28,000 and $26,000, respectively. Amortization expense for the six months ended March 31, 2018 and 2017 was $56,000 and $52,000, respectively.
 
Estimated amortization expense for each of the next five fiscal years and thereafter is as follows:
 
 
 
2018 (6 months)
 
2019
 
2020
 
2021
 
2022
 
Thereafter
 
Total
 
Acquired Customer Base
 
$
40,000
 
$
80,000
 
$
41,000
 
$
-
 
$
-
 
$
-
 
$
161,000
 
Know How
 
 
17,000
 
 
34,000
 
 
34,000
 
 
34,000
 
 
34,000
 
 
26,000
 
 
179,000
 
Patents
 
 
6,000
 
 
11,000
 
 
11,000
 
 
11,000
 
 
11,000
 
 
162,000
 
 
212,000
 
 
 
$
63,000
 
$
125,000
 
$
86,000
 
$
45,000
 
$
45,000
 
$
188,000
 
$
552,000
 
 
As of March 31, 2018, Xcede had $152,000 in patents that have not been granted, therefore, the amortization related to these patents is not included in the five-year amortization table above.
 
The Company continually assesses whether events or changes in circumstances have occurred that may warrant revision of the estimated useful lives of its long-lived assets or whether the remaining balances of those assets should be evaluated for possible impairment. There were no changes, aside from foreign exchange rate fluctuations, in the carrying value of long-lived assets, during the six months ended March 31, 2018.